Correspondence 0001213900-24-034103 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: April 18, 2024 · CIK: 0001711786 · Accession: 0001213900-24-034103
AI Filing Summary & Sentiment
File numbers found in text: 333-278620
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics,
Inc.
590 Madison Ave., 21st Floor
New York, NY 10022
April 18, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-278620
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Friday, April 19, 2024, or as soon thereafter as possible.
Please notify Emily Mastoloni
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 896-0675 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer